Figure 1 | Scientific Reports

Figure 1

From: Analysis of survival and prognostic factors of clear cell adenocarcinoma of the prostate: a case–control study for a rare cancer entity

Figure 1

The survival rates of CCPC patients compared with those with APC. (1A) CPCC patients had a higher ratio of CSM (41.5% vs. 20.0%); (1B) CPCC patients had a higher ratio of OM (99.2% vs. 68.1%) (both p < 0.001). CCPC = Clear cell adenocarcinoma of the prostate; APC = acinar carcinoma of the prostate; CSM = cancer-specific mortality; OM = overall mortality.

Back to article page